Ensysce Biosciences, Inc. (ENSC)

NASDAQ: ENSC · USD

$0.45

+0.00 (+0.4%)· Recorded snapshot

Market cap	8.8M
Revenue (ttm)	4.5M
Net income (ttm)	-12.6M
EPS (ttm)	-$1.90
Shares out	19.5M
Volume	55,365
Beta	1.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.5M
Net income (ttm): -12.6M
EPS (ttm): -$1.90
Market cap: 8.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-1,295.1

P25 n/aP50 n/aP75 n/a

ROIC-615.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ENSC indicators

Market & fundamental data

Available fields

190

Groups with data

Currency

USD

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001716947
Company name	Ensysce Biosciences, Inc.
Country	United States
Country code	US
CUSIP number	293602504
Earnings date	2026-11-13
Earnings time	amc
Employees	10
Employees change	2
Employees growth	25%
Enterprise value	$8.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2003
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US2936025046
Last 10-K release date	2026-03-30
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2024-12-06
Last stock split type	Reverse
Market cap	$8.8M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$0.45
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ENSC
U.S. state	California
Website	https://www.ensysce.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-421.34%
EV/Sales	1.84x
FCF / EV yield	-108.52%
FCF yield	-102.58%
Forward EV/Sales	1.53x
Forward P/S	1.62x
P/S ratio	1.94x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-281.32%
Gross margin	-175.21%
Operating margin	-281.32%
Pretax margin	-280.5%
Profit margin	-280.48%
Profit per employee	$-1.3M
Revenue per employee	$450,075
ROA	-185.51%
ROA (5Y)	-127.84%
ROCE	1,139.82%
ROE	-1,295.09%
ROIC	-615.61%
SBC / revenue	26.5%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	4
Net income growth years	0
Revenue growth	-39.29%
Revenue growth (Q)	-15.1%
Revenue growth (QoQ)	21.16%
Revenue growth 3Y	14.57%
Revenue growth 5Y	18.34%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-123,643
Depreciation and amortization	$19,599
EBIT	$-12.7M
EPS	$-1.90
FCF per share	$-0.46
Financing cash flow	$7.4M
Free cash flow	$-9M
Free cash flow minus SBC	$-10.2M
Gross profit	$-7.9M
Investing cash flow	$-123,643
Net borrowing	$-208,939
Net cash flow	$-1.5M
Net income	$-12.6M
Operating cash flow minus SBC	$-10M
Operating income	$-12.7M
Revenue	$4.5M
Stock-based compensation	$1.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-81.47
Book value per share	$-0.05
Interest coverage	-791.69
Long-term assets	$111,063
Long-term liabilities	$0
Net cash (debt)	$479,862
Net cash / market cap	5.48%
Net cash growth	-73.15%
Piotroski F-Score	1
Property, plant and equipment	$111,063
Shareholders' equity	$-1.1M
Tangible book value	$-781,697
Tangible book value per share	$-0.05
Total assets	$3M
Total cash	$676,704
Total debt	$196,842
Total liabilities	$4.1M
WACC	9.76%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.06
Current assets	$2.8M
Current liabilities	$4.1M
Current ratio	0.7
Net working capital	$-1.7M
Quick ratio	0.27
Working capital	$-1.2M
Working capital turnover	5.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-393.27%
Dividend yield	0%
Shareholder yield	-393.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$0.39
1D price change	0.4%
1M price change	9.8%
1M total return	9.8%
1W price change	-9.21%
1W total return	-9.21%
1Y price change	-78.85%
1Y return CAGR	-78.87%
1Y total return	-78.85%
20-day SMA	$0.49
200-day SMA	$0.44
3M price change	73.05%
3M total return	73.05%
3Y price change	-97.04%
3Y return CAGR	-69.06%
3Y total return	-97.04%
50-day SMA	$0.45
50-day SMA vs 200-day SMA	50over200
52-week high	$2.23
52-week high date	2025-11-03
52-week low	$0.23
52-week low date	2026-05-14
5Y price change	-99.99%
5Y return CAGR	-85.82%
5Y total return	-99.99%
6M price change	18.32%
6M total return	18.32%
All-time high	$86,363.99
All-time high date	2021-02-01
All-time low	$0.23
All-time low date	2026-05-14
Average true range (ATR)	$0.05
Average volume	574.1K
Beta (1Y)	3.23
Beta (2Y)	2.45
Beta (5Y)	1.02
Change from 52-week high	-79.74%
Change from 52-week low	96.39%
Change from all-time high	-100%
Change from all-time low	96.83%
Change from open	0%
Day's gap	0.4%
Dollar volume	$25,008
High price	$0.45
Low price	$0.45
Monthly RSI	28.66
Open price	$0.45
Previous close	$0.45
Price vs 150-day SMA	17.28%
Price vs 20-day SMA	-6.85%
Price vs 200-day SMA	3.59%
Price vs 50-day SMA	0.58%
Relative volume	0.1
RSI	45.92
Sharpe ratio	-0.57
Sharpe ratio (3Y)	-0.13
Sharpe ratio (5Y)	-0.48
Sortino ratio	-0.94
Sortino ratio (3Y)	-0.23
Sortino ratio (5Y)	-0.87
Volume	55.4K
Weekly RSI	46.29
YTD price change	-50.79%
YTD total return	-50.79%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18.5M
Float percentage	95.28%
Shares change (QoQ)	90.6%
Shares change (YoY)	393.27%
Shares held by insiders	4.72%
Shares held by institutions	4.65%
Shares outstanding	19.5M
Short % of float	1.64%
Short % of shares	1.56%
Short ratio	2.1 days

Deeper analysis on ENSC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ENSC report

Is a complete ENSC research report available?

No complete published report is available for Ensysce Biosciences, Inc. (ENSC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Ensysce Biosciences, Inc. (ENSC)

Price

Financial snapshot

Fair-value bridge

Latest news · ENSC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ENSC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ENSC

Frequently asked questions